IBDEI10C ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16388,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,16389,0)
 ;;=R80.3^^61^772^93
 ;;^UTILITY(U,$J,358.3,16389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16389,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,16389,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,16389,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,16390,0)
 ;;=R80.9^^61^772^98
 ;;^UTILITY(U,$J,358.3,16390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16390,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,16390,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,16390,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,16391,0)
 ;;=Z87.442^^61^772^86
 ;;^UTILITY(U,$J,358.3,16391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16391,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,16391,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,16391,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,16392,0)
 ;;=N18.1^^61^772^15
 ;;^UTILITY(U,$J,358.3,16392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16392,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,16392,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,16392,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,16393,0)
 ;;=N18.2^^61^772^16
 ;;^UTILITY(U,$J,358.3,16393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16393,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,16393,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,16393,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,16394,0)
 ;;=N18.4^^61^772^20
 ;;^UTILITY(U,$J,358.3,16394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16394,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,16394,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,16394,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,16395,0)
 ;;=N18.5^^61^772^21
 ;;^UTILITY(U,$J,358.3,16395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16395,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,16395,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,16395,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,16396,0)
 ;;=Q61.3^^61^772^89
 ;;^UTILITY(U,$J,358.3,16396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16396,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,16396,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,16396,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,16397,0)
 ;;=N20.1^^61^772^11
 ;;^UTILITY(U,$J,358.3,16397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16397,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,16397,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,16397,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,16398,0)
 ;;=N18.9^^61^772^22
 ;;^UTILITY(U,$J,358.3,16398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16398,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,16398,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,16398,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,16399,0)
 ;;=N18.6^^61^772^32
 ;;^UTILITY(U,$J,358.3,16399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16399,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,16399,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,16399,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,16400,0)
 ;;=N52.9^^61^772^49
 ;;^UTILITY(U,$J,358.3,16400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16400,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,16400,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,16400,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,16401,0)
 ;;=N32.81^^61^772^84
 ;;^UTILITY(U,$J,358.3,16401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16401,1,3,0)
 ;;=3^Overactive Bladder
